2024 Europe Therapeutic Drug Monitoring (TDM) Market for 28 Assays--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers

August 2024 | - | ID: 2E6C88156A0EEN
Venture Planning Group

Abstracts

This new 291-page report from LeadingMarketResearch provides a comprehensive analysis of the European therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report is available by section, and can be customized to specific information needs and budget.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran, Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin, and Warfarin.During the next five years, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.This unique market and technology assessment is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.Contains 291 pages and 61 tables

Contents

Introduction
Market and Technology Overview
A. Major Therapeutic Drug Monitoring Tests

1. OVERVIEW

2. AMIKACIN

3. APIXABAN

4. ARGATROBAN

5. BETRIXABAN

6. CARBAMAZEPINE

7. CYCLOSPORIN

8. DABIGATRAN

9. DIGOXIN

10. EDOXABAN

11. EVEROLIMUS

12. FLUINDIONE

13. GENTAMICIN

14. LEVETIRACETAM

15. LITHIUM

16. METHOTREXATE

17. NAPA/PROCAINAMIDE

18. PHENOBARBITAL

19. PHENYTOIN

20. QUINIDINE

21. RIVAROXABAN

22. SIROLIMUS

23. TACROLIMUS

24. THEOPHYLLINE

25. TOBRAMYCIN

26. TOPIRIMATE

27. VALPROIC ACID

28. VANCOMYCIN

29. WARFARIN

B. Instrumentation Review: Operating characteristics and
features of high-, medium-, and low-volume/POC analyzers
manufactured by Abaxis, Abbott, Alfa Wassermann, AMS,
Awareness Technologies, Beckman Coulter, Binding Site,
bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba,
Medica, Nova Biomedical, Ortho-Clinical Diagnostics,
Polymedco, Randox, Roche, Siemens, Tosoh, Vital Diagnostics
and other suppliers.
Table of Contents (Continued)
C. Major In Vitro Diagnostic Technologies
And Their Potential Applications

1. MONOCLONAL AND POLYCLONAL ANTIBODIES

2. IMMUNOASSAYS

a. Technological Principle
b. Chemiluminescence
c. Enzyme Immunoassays (EIA)
° Overview
° ELISA
° EMIT
° Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography

3. TANDEM MASS SPEC

4. IT AND AUTOMATION

5. DRY CHEMISTRY

6. BIOSENSORS

France: Test Volume and Sales Forecasts by Assay and Market Segment,
And Major Supplier Market Shares
Germany: Test Volume and Sales Forecasts by Assay and Market Segment,
And Major Supplier Market Shares
Italy: Test Volume and Sales Forecasts by Assay and Market Segment,
And Major Supplier Market Shares
Spain: Test Volume and Sales Forecasts by Assay and Market Segment,
And Major Supplier Market Shares
UK: Test Volume and Sales Forecasts by Assay and Market Segment,
And Major Supplier Market Shares